LANZA, Marika
 Distribuzione geografica
Continente #
NA - Nord America 2.361
EU - Europa 1.590
AS - Asia 1.398
SA - Sud America 531
AF - Africa 40
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.929
Nazione #
US - Stati Uniti d'America 2.286
SG - Singapore 638
BR - Brasile 468
IE - Irlanda 416
CN - Cina 314
IT - Italia 312
SE - Svezia 261
HK - Hong Kong 181
DE - Germania 144
PL - Polonia 126
VN - Vietnam 72
FI - Finlandia 51
IN - India 50
GB - Regno Unito 43
FR - Francia 41
RU - Federazione Russa 41
CA - Canada 35
UA - Ucraina 34
MX - Messico 33
AR - Argentina 27
AT - Austria 26
TR - Turchia 26
NL - Olanda 25
ID - Indonesia 20
ES - Italia 19
JP - Giappone 17
ZA - Sudafrica 15
BD - Bangladesh 13
BE - Belgio 13
CZ - Repubblica Ceca 13
EC - Ecuador 11
MA - Marocco 9
UZ - Uzbekistan 9
IQ - Iraq 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
IL - Israele 6
NP - Nepal 6
NZ - Nuova Zelanda 6
PK - Pakistan 6
CO - Colombia 5
JO - Giordania 5
KG - Kirghizistan 5
LT - Lituania 5
TN - Tunisia 5
AZ - Azerbaigian 4
BG - Bulgaria 3
BY - Bielorussia 3
CH - Svizzera 3
CL - Cile 3
DZ - Algeria 3
HU - Ungheria 3
KE - Kenya 3
PE - Perù 3
PY - Paraguay 3
AU - Australia 2
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GR - Grecia 2
PA - Panama 2
SA - Arabia Saudita 2
SC - Seychelles 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
DK - Danimarca 1
DM - Dominica 1
EG - Egitto 1
GN - Guinea 1
IS - Islanda 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.929
Città #
Ashburn 487
Dublin 416
Chandler 310
Dallas 299
Singapore 278
Nyköping 216
Hong Kong 176
Messina 129
Beijing 122
Warsaw 122
Los Angeles 84
New York 84
Munich 82
The Dalles 67
Princeton 50
Medford 40
Boardman 39
São Paulo 36
Buffalo 30
Ho Chi Minh City 28
Redondo Beach 28
Des Moines 23
Catania 22
Frankfurt am Main 21
Ann Arbor 19
Rio de Janeiro 19
Turku 19
Montreal 18
Nuremberg 18
Pune 18
Helsinki 17
Vienna 17
Piazza Armerina 16
Düsseldorf 15
Jakarta 15
Brooklyn 14
Lappeenranta 14
Tokyo 14
Wilmington 14
Boston 13
Moscow 13
Brussels 12
Chennai 12
Jacksonville 12
Atlanta 11
Rome 11
San Francisco 11
Stockholm 11
Denver 10
London 10
Marsala 10
Poplar 10
Querétaro 10
Santa Clara 10
Washington 10
Amsterdam 9
Ankara 9
Belo Horizonte 9
Hanoi 9
Hyderabad 9
Jinan 9
Johannesburg 9
Shanghai 9
Tashkent 9
Tianjin 9
Brno 8
Chicago 8
Curitiba 8
Dong Ket 8
Fortaleza 8
Palermo 8
Mexico City 7
Orem 7
Seattle 7
Campinas 6
Falls Church 6
Guayaquil 6
Istanbul 6
Manchester 6
Milan 6
Phoenix 6
Portsmouth 6
Tappahannock 6
Whakatane 6
Bexley 5
Bishkek 5
Francofonte 5
Guangzhou 5
Guarulhos 5
Juiz de Fora 5
Lauterbourg 5
Pelotas 5
Porto Alegre 5
Roubaix 5
Salvador 5
Zhengzhou 5
Amman 4
Annapolis 4
Baku 4
Brasília 4
Totale 3.907
Nome #
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 157
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 137
Dimethyl fumarate attenuates neuroinflammation and neurobehavioral deficits induced by experimental traumatic brain injury 120
Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice 118
TAK1 inhibitor enhances the therapeutic treatment for glioblastoma 117
Evaluation of a Product Containing Xyloglucan and Pea Protein on Skin Barrier Permeability 117
BAY-117082-driven NLRP3 inflammasome inhibition resolves nitro-glycerine (NTG) neuronal damage in in vivo model of migraine 116
Human hepatitis B virus negatively impacts the protective immune cross-talk between natural killer and dendritic cells 115
Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma 115
Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies 114
Protein Hydrolysates from Anchovy (Engraulis encrasicolus) Waste: In Vitro and In Vivo Biological Activities 114
Effect of a Product Containing Xyloglucan and Pea Protein on a Murine Model of Atopic Dermatitis 112
Effect of ultra-micronized-palmitoylethanolamide and acetyl-l-carnitine on experimental model of inflammatory pain 110
Efficacy of Xyloglucan against Escherichia coli Extraintestinal Urinary Tract Infection: An in vivo Study 109
TLR-4/Wnt modulation as new therapeutic strategy in the treatment of glioblastomas 101
Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal Model 99
Multiple mechanisms of dimethyl fumarate in amyloid β-induced neurotoxicity in human neuronal cells 98
The protective role of prolyl oligopeptidase (pop) inhibition in acute lung injury induced by intestinal ischemia-reperfusion 98
A Combination of Xyloglucan, Pea Protein and Chia Seed Ameliorates Intestinal Barrier Integrity and Mucosa Functionality in a Rat Model of Constipation-Predominant Irritable Bowel Syndrome 96
A New Approach for the Treatment of Recurrent Vulvovaginal Candidiasis with a Combination of Pea Protein, Grape Seed Extract, and Lactic Acid Assessed In Vivo 96
Protective effects of xyloglucan in association with the polysaccharide gelose in an experimental model of gastroenteritis and urinary tract infections 94
The anti-inflammatory and antioxidant effects of sodium propionate 94
Therapeutic potential of flavonoids in the treatment of chronic venous insufficiency 93
Dimethyl Fumarate (DMF) Alleviated Post-Operative (PO) Pain through the N-Methyl-d-Aspartate (NMDA) Receptors 92
Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC) 88
Evaluation of the nutraceutical Palmitoylethanolamide in reducing intraocular pressure (IOP) in patients with glaucoma or ocular hypertension: a systematic review and meta-analysis 88
Adenosine Targeting as a New Strategy to Decrease Glioblastoma Aggressiveness 87
NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression 86
Potential Therapeutic Effects of PPAR Ligands in Glioblastoma 85
Modulation of NLRP3 inflammasome attenuated inflammatory response associated to diarrhea-predominant irritable bowel syndrome 83
Sodium Propionate Contributes to Tumor Cell Growth Inhibition through PPAR-γ Signaling 82
The protective role of prolyl oligopeptidase (Pop) inhibition in kidney injury induced by renal ischemia–reperfusion 82
Evaluating the Protective Properties of a Xyloglucan-Based Nasal Spray in a Mouse Model of Allergic Rhinitis 80
Evaluation of a Gel Containing a Propionibacterium Extract in an In Vivo Model of Wound Healing 77
The inhibition of prolyl oligopeptidase as new target to counteract chronic venous insufficiency: Findings in a mouse model 77
Poly (Adp-ribose) polymerase inhibitor, abt888, improved cisplatin effect in human oral cell carcinoma 77
PD1/PD-L1 immune checkpoint as a potential target for preventing brain tumor progression 77
Inhibition of Prolyl Oligopeptidase Prevents Consequences of Reperfusion following Intestinal Ischemia 76
Effect of pea protein plus grape seed dry extract on a murine model of Candida albicans induced vaginitis 75
Topical delivery of curcumin by choline-calix[4]arene-based nanohydrogel improves its therapeutic effect on a psoriasis mouse model 74
Synergic therapeutic potential of PEA-Um treatment and NAAA enzyme silencing in the management of neuroinflammation 73
Efficacy of an oral suspension containing xyloglucan and pea proteins on a murine model of gastroesophageal reflux disease 72
Rebalancing NOX2/Nrf2 to limit inflammation and oxidative stress across gut-brain axis in migraine 72
Role of ABT888, a Novel Poly(ADP-Ribose) Polymerase (PARP) Inhibitor in Countering Autophagy and Apoptotic Processes Associated to Spinal Cord Injury 72
Pea-oxa mitigates oxaliplatin-induced painful neuropathy through nf-κb/nrf-2 axis 70
Effect of Melatonin on Psoriatic Phenotype in Human Reconstructed Skin Model 70
Protective effect of sodium propionate in Aβ1-42 -induced neurotoxicity and spinal cord trauma 70
Immunomodulatory effect of microglia-released cytokines in gliomas 67
Efficacy of a Novel Therapeutic, Based on Natural Ingredients and Probiotics, in a Murine Model of Multiple Food Intolerance and Maldigestion 67
Neuroprotective effects of GSK-343 in an in vivo model of MPTP-induced nigrostriatal degeneration 65
TBK1 Inhibitor Exerts Antiproliferative Effect on Glioblastoma Multiforme Cells 65
bFGF-like Activity Supported Tissue Regeneration, Modulated Neuroinflammation, and Rebalanced Ca2+ Homeostasis following Spinal Cord Injury 64
The inhibition of mammalian target of rapamycin (mTOR) in improving inflammatory response after traumatic brain injury 64
Properties of a new food supplement containing Actinia equina extract 62
Therapeutic Potential of Dimethyl Fumarate in Counteract Oral Squamous Cell Carcinoma Progression by Modulating Apoptosis, Oxidative Stress and Epithelial–Mesenchymal Transition 62
Ulva pertusa, a Marine Green Alga, Attenuates DNBS-Induced Colitis Damage via NF-κB/Nrf2/SIRT1 Signaling Pathways 60
The Pivotal Role of Protein Phosphatase 2A (PP2A) in Brain Tumors 60
Treatment with luteolin improves lipopolysaccharide‐induced periodontal diseases in rats 60
SCFA Treatment Alleviates Pathological Signs of Migraine and Related Intestinal Alterations in a Mouse Model of NTG-Induced Migraine 60
Tlr7/8 in the pathogenesis of parkinson’s disease 59
An RNAi-Mediated Reduction in Transcription Factor Nrf-2 Blocks the Positive Effects of Dimethyl Fumarate on Metabolic Stress in Alzheimer's Disease 58
Effect of a combination of pea protein, grape seed extract and lactic acid in an in vivo model of bacterial vaginosis 57
Protein Kinase Inhibitors as a New Target for Immune System Modulation and Brain Cancer Management 56
SUN11602, a bFGF mimetic, modulated neuroinflammation, apoptosis and calcium-binding proteins in an in vivo model of MPTP-induced nigrostriatal degeneration 55
The Biological Function of MicroRNAs in Bone Tumors 52
Supplementation with SCFAs Re-Establishes Microbiota Composition and Attenuates Hyperalgesia and Pain in a Mouse Model of NTG-Induced Migraine 52
Evaluation of the Efficacy of Xyloglucan, Pea Protein and Opuntia ficus-indica Extract in a Preclinical Model of Psoriasis 51
Sodium Butyrate Exerts Neuroprotective Effects in Spinal Cord Injury 51
Benzyl isothiocyanate suppresses development of thyroid carcinoma by regulating both autophagy and apoptosis pathway 50
The Transcription Factor Nrf2 Mediates the Effects of Antrodia camphorata Extract on Neuropathological Changes in a Mouse Model of Parkinson’s Disease 49
null 48
Role of Basic Fibroblast Growth Factor in Cancer: Biological Activity, Targeted Therapies, and Prognostic Value 46
Inhibition of LRRK2 Attenuates Depression-Related Symptoms in Mice with Moderate Traumatic Brain Injury 40
The Inhibition of Prolyl Endopeptidase (PREP) by KYP-2047 Treatment to Reduce Myocardial Ischemia/Reperfusion Injury 38
The Protective Role of Troxerutin (Trox) in Counteracting Anaplastic Thyroid Carcinoma (ATC) Progression 34
Overview on Common Genes Involved in the Onset of Glioma and on the Role of Migraine as Risk Factor: Predictive Biomarkers or Therapeutic Targets? 31
CK and LRRK2 Involvement in Neurodegenerative Diseases 27
The Role of miR-128 in Neurodegenerative Diseases 26
PI3K/mTOR Signaling Pathway Dual Inhibition for the Management of Neuroinflammation: Novel Insights from In Vitro Models 25
GIT 27 modulates TLR4/Src/NOX2 signaling pathway: A potential therapeutic strategy to decrease neuroinflammation, oxidative stress and neuronal cell death in Parkinson's disease 18
null 15
PF-04691502, a PI3K/mTOR Dual Inhibitor, Ameliorates AD-like Pathology in a Mouse Model of AD 8
A Topical Combination of Xyloglucan and Pea Protein Effectively Manages Oral Ulcers In Vivo 5
Totale 6.132
Categoria #
all - tutte 28.726
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.726


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021156 0 0 0 0 0 11 30 40 38 18 9 10
2021/2022327 3 15 10 3 20 7 12 14 27 11 50 155
2022/20231.163 88 112 45 91 64 134 18 54 511 5 33 8
2023/2024435 16 55 25 41 30 149 8 13 1 14 6 77
2024/20251.766 36 10 66 91 91 87 85 294 402 129 225 250
2025/20262.016 369 305 404 389 514 35 0 0 0 0 0 0
Totale 6.132